Please Wait

Applying Filters...

Fluorescein
CEP/COS
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Fluorescein

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 7 USDMF, 1 CEP/COS, 2 NDC API, 9 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 2 FDA Orange Book, 4 Europe, 2 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.25%, SOLUTION/DROPS;OPHTHALMIC - 0.4%;0.3%

RELATED EXCIPIENT COMPANIES

1 DKSH, 1 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Actylis, 9 BASF, 1 Gangwal Chemicals, 1 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Pluviaendo

EXCIPIENTS BY APPLICATIONS

6 Fillers, Diluents & Binders, 6 Solubilizers, 5 Granulation, 3 Direct Compression, 3 Parenteral, 3 Controlled & Modified Release, 1 Coating Systems & Additives, 1 Disintegrants & Superdisintegrants, 1 Thickeners and Stabilizers, 1 Topical, 1 Film Formers & Plasticizers